Young adults with Fabry disease in Canada are at a significantly higher risk of experiencing a first-time stroke or…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
A one-time infusion of gene therapy ST-920 (isaralgagene civaparvovec) improved kidney function and stabilized heart function in adults with…
Noninvasive echocardiogram imaging may serve as an early marker for left ventricular hypertrophy (LVH), a disease of the left…
In what researchers say is the first reported case of its kind, a woman in China in her 60s was…
Enzyme replacement therapy (ERT) preserved or improved heart function in two men with Fabry disease who had already…
Noninvasive in vivo confocal microscopy (IVCM) detected signs of nerve damage in the cornea — the eye’s transparent outer layer…
People with Fabry disease spend an average of six hours on activities related to a single treatment with an…
A new mutation in the GLA gene was identified as the cause of Fabry disease in two people who turned…
Family planning is the main event in a woman’s life that’s most affected by Fabry disease, while passing the…
Up to 20 years of treatment with agalsidase alfa slowed declines in kidney and heart function, and extended…